Dorian Paul LeBlanc - 10 Dec 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Reporting relationship: Chief Financial Officer
Issuer ticker: LMAT
Reported as of: 10 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Dec 2025, 18:10:11 UTC
Prior SEC filing: 08 Dec 2025
Next SEC filing: 12 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

Dorian Paul LeBlanc filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 11 Dec 2025.

Key facts

This page summarizes Dorian Paul LeBlanc's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Dec 2025, 18:10.

Change

Previous filing in this sequence was filed on 08 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002061481 Primary reporting owner

LeBlanc Dorian Paul

Relationship: Chief Financial Officer
Address: C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Signature date: 11 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMAT transaction

Common Stock

Award

Transaction value: $0
Shares: +1,177
Change %: +96%
Price: $0.000000
Shares after: 2,398
Date: 10 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +7,222
Change %
Price: $0.000000
Shares after: 7,222
Date: 10 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,222
Exercise price: $83.66
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.

Footnote F2

This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.